dc.contributor.author | Atis, S | |
dc.contributor.author | Tutluoglu, B | |
dc.contributor.author | Abanozlu, S | |
dc.contributor.author | Gurbuz, N | |
dc.contributor.author | Kanik, A | |
dc.contributor.author | Ibis, R | |
dc.date.accessioned | 2021-03-03T20:31:30Z | |
dc.date.available | 2021-03-03T20:31:30Z | |
dc.date.issued | 2001 | |
dc.identifier.citation | Tutluoglu B., Gurbuz N., Atis S., Abanozlu S., Ibis R., Kanik A., "Effects of heparin on hypertonic potassium chloride-induced bronchoconstriction", ANNALS OF PHARMACOTHERAPY, cilt.35, sa.10, ss.1161-1165, 2001 | |
dc.identifier.issn | 1060-0280 | |
dc.identifier.other | av_5a65f38f-a98a-4d2e-bf5f-05db709536c0 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/63532 | |
dc.identifier.uri | https://doi.org/10.1345/aph.10140 | |
dc.description.abstract | BACKGROUND: Changes in bronchial osmolarity Is a well-known factor for bronchoconstriction. Recently, nonisotonic aerosols have begun to be used for the assessment of bronchial hyperreactivity. Hypertonic KCl can cause bronchoconstriction even in nonsymptomatic asthmatic patents. | |
dc.language.iso | eng | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Temel Bilimler | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.title | Effects of heparin on hypertonic potassium chloride-induced bronchoconstriction | |
dc.type | Makale | |
dc.relation.journal | ANNALS OF PHARMACOTHERAPY | |
dc.contributor.department | , , | |
dc.identifier.volume | 35 | |
dc.identifier.issue | 10 | |
dc.identifier.startpage | 1161 | |
dc.identifier.endpage | 1165 | |
dc.contributor.firstauthorID | 163315 | |